These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

419 related articles for article (PubMed ID: 37004014)

  • 21. Supramolecular nanotherapeutics enable metabolic reprogramming of tumor-associated macrophages to inhibit tumor growth.
    Ramesh A; Malik V; Brouillard A; Kulkarni A
    J Biomed Mater Res A; 2022 Aug; 110(8):1448-1459. PubMed ID: 35388955
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Nanomaterials-Involved Tumor-Associated Macrophages' Reprogramming for Antitumor Therapy.
    Li SL; Hou HY; Chu X; Zhu YY; Zhang YJ; Duan MD; Liu J; Liu Y
    ACS Nano; 2024 Mar; 18(11):7769-7795. PubMed ID: 38420949
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The role of tumor-associated macrophage in breast cancer biology.
    Choi J; Gyamfi J; Jang H; Koo JS
    Histol Histopathol; 2018 Feb; 33(2):133-145. PubMed ID: 28681373
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Pulmonary administration of a CSF-1R inhibitor alters the balance of tumor-associated macrophages and supports first-line chemotherapy in a lung cancer model.
    Zhang H; Almuqbil RM; Alhudaithi SS; Sunbul FS; da Rocha SRP
    Int J Pharm; 2021 Apr; 598():120350. PubMed ID: 33545279
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Targeting lipid metabolism to overcome EMT-associated drug resistance via integrin β3/FAK pathway and tumor-associated macrophage repolarization using legumain-activatable delivery.
    Jin H; He Y; Zhao P; Hu Y; Tao J; Chen J; Huang Y
    Theranostics; 2019; 9(1):265-278. PubMed ID: 30662566
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Influencing Factors and Significance of Tumor-associated Macrophage Polarization 
in Tumor Microenvironment].
    Ge W; Wu W
    Zhongguo Fei Ai Za Zhi; 2023 Mar; 26(3):228-237. PubMed ID: 37035885
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Unveiling the veil of lactate in tumor-associated macrophages: a successful strategy for immunometabolic therapy.
    Tao H; Zhong X; Zeng A; Song L
    Front Immunol; 2023; 14():1208870. PubMed ID: 37564659
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Lipid Metabolic Regulatory Crosstalk Between Cancer Cells and Tumor-Associated Macrophages.
    Liu S; Shen YY; Yin LY; Liu J; Zu X
    DNA Cell Biol; 2023 Aug; 42(8):445-455. PubMed ID: 37535386
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Tumor-associated macrophage-specific CD155 contributes to M2-phenotype transition, immunosuppression, and tumor progression in colorectal cancer.
    Zhu X; Liang R; Lan T; Ding D; Huang S; Shao J; Zheng Z; Chen T; Huang Y; Liu J; Pathak JL; Wei H; Wei B
    J Immunother Cancer; 2022 Sep; 10(9):. PubMed ID: 36104099
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Metabolism in tumour-associated macrophages: a
    Zheng X; Mansouri S; Krager A; Grimminger F; Seeger W; Pullamsetti SS; Wheelock CE; Savai R
    Eur Respir Rev; 2020 Sep; 29(157):. PubMed ID: 33004525
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Tumor-associated macrophages as a potential therapeutic target in thyroid cancers.
    Zhu L; Li XJ; Gangadaran P; Jing X; Ahn BC
    Cancer Immunol Immunother; 2023 Dec; 72(12):3895-3917. PubMed ID: 37796300
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Polarization of M2 Tumor-Associated Macrophages (TAMs) in Cancer Immunotherapy.
    Bui I; Bonavida B
    Crit Rev Oncog; 2024; 29(4):75-95. PubMed ID: 38989739
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Oncometabolites lactate and succinate drive pro-angiogenic macrophage response in tumors.
    Kes MMG; Van den Bossche J; Griffioen AW; Huijbers EJM
    Biochim Biophys Acta Rev Cancer; 2020 Dec; 1874(2):188427. PubMed ID: 32961257
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Tumor cell-released autophagosomes (TRAPs) promote immunosuppression through induction of M2-like macrophages with increased expression of PD-L1.
    Wen ZF; Liu H; Gao R; Zhou M; Ma J; Zhang Y; Zhao J; Chen Y; Zhang T; Huang F; Pan N; Zhang J; Fox BA; Hu HM; Wang LX
    J Immunother Cancer; 2018 Dec; 6(1):151. PubMed ID: 30563569
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Nanomedicine-based cancer immunotherapies developed by reprogramming tumor-associated macrophages.
    Li X; Guo X; Ling J; Tang Z; Huang G; He L; Chen T
    Nanoscale; 2021 Mar; 13(9):4705-4727. PubMed ID: 33625411
    [TBL] [Abstract][Full Text] [Related]  

  • 36. C1q
    Zhang S; Peng W; Wang H; Xiang X; Ye L; Wei X; Wang Z; Xue Q; Chen L; Su Y; Zhou Q
    J Immunother Cancer; 2023 Aug; 11(8):. PubMed ID: 37604643
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Tumor-Associated Macrophages in Tumor Immunity.
    Pan Y; Yu Y; Wang X; Zhang T
    Front Immunol; 2020; 11():583084. PubMed ID: 33365025
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Revisiting of TAMs in tumor immune microenvironment: Insight from NF-κB signaling pathway.
    He R; He Y; Du R; Liu C; Chen Z; Zeng A; Song L
    Biomed Pharmacother; 2023 Sep; 165():115090. PubMed ID: 37390708
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Immunometabolic attributes and mitochondria-associated signaling of Tumor-Associated Macrophages in tumor microenvironment modulate cancer progression.
    Dubey S; Ghosh S; Goswami D; Ghatak D; De R
    Biochem Pharmacol; 2023 Feb; 208():115369. PubMed ID: 36481347
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Functional polarization of tumor-associated macrophages dictated by metabolic reprogramming.
    Zeng W; Li F; Jin S; Ho PC; Liu PS; Xie X
    J Exp Clin Cancer Res; 2023 Sep; 42(1):245. PubMed ID: 37740232
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 21.